Radiography
Volume 13 , Pages e2-e4 , December 2007

MRI in 2007 – The state of the art

  • Wayne Patola

      Affiliations

    • Corresponding Author InformationTel.: +1 604 682 2344x62891; fax: +1 604 806 8283.

Received 27 January 2007

References 

  1. Grand D, Bluemke DA. MRI Determination of myocardial viability. Applied Radiology. 2006;35(6):
  2. Sun B, Giddens DP, Long R. Characterization of coronary atherosclerotic plaque using multicontrast MRI acquired under simulated in vivo conditions. JMRI. 2006;24(4):833–841
  3. Sinha S, Sinha U, Edgerton VR. In vivo diffusion tensor imaging of the human calf muscle. JMRI. 2006;24:182–190
  4. Kiehl KA, Smith AM, Mendrek A, Forster BB, Hare RD, Liddle PF. Temporal lobe abnormalities in semantic processing by criminal psychopaths as revealed by functional magnetic resonance imaging. Psychiatry Research: Neuroimaging. 2004;130:27–42
  5. Ross JS, Tkacha J, Ruggieri PM, Lieber M, Lapresto E. The mind's eye: functional MR imaging evaluation of golf motor imagery. American Journal of Neuroradiology. 2003;24:1036–1044
  6. Sorensen AG. Magnetic resonance as a cancer imaging biomarker. J Clin Oncol. 2006;24(20):3274–3281
  7. Greenman RL, Rakow-Penner R. Evaluation of the RF field uniformity of a double-tuned 31P/1H birdcage RF coil for spin-echo MRI/MRS of the diabetic foot. JMRI. 2005;22:427–432
  8. Eriksson R, Johansson L, Bjerner T, Karlsson JOG, Ahlstrom H. Contrast enhancement of manganese-hydroxypropyl-tetraacetic acid, an MR contrast agent with potential for detecting differences in myocardial blood flow. JMRI. 2006;24:858–863

 The author receives support from GE Healthcare Canada, but no content of the article is in conflict of interest or promotes the business of GE Healthcare Canada.

PII: S1078-8174(07)00017-X

doi: 10.1016/j.radi.2007.03.003

Radiography
Volume 13 , Pages e2-e4 , December 2007